Taylor Ryan McFarland

495 total citations
17 papers, 318 citations indexed

About

Taylor Ryan McFarland is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Taylor Ryan McFarland has authored 17 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 10 papers in Cancer Research and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Taylor Ryan McFarland's work include Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Cancer, Lipids, and Metabolism (6 papers). Taylor Ryan McFarland is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Cancer, Lipids, and Metabolism (6 papers). Taylor Ryan McFarland collaborates with scholars based in United States. Taylor Ryan McFarland's co-authors include Umang Swami, Neeraj Agarwal, Roberto Nussenzveig, Benjamin L. Maughan, Nicolas Sayegh, Nityam Rathi, Deepika Sirohi, Manish Kohli, Nishita Tripathi and Benjamin Haaland and has published in prestigious journals such as Journal of Clinical Oncology, Drugs and Molecular Cancer Therapeutics.

In The Last Decade

Taylor Ryan McFarland

16 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taylor Ryan McFarland United States 7 214 115 88 87 66 17 318
Mamta Parikh United States 11 167 0.8× 172 1.5× 150 1.7× 59 0.7× 94 1.4× 62 429
Ning Liao China 10 84 0.4× 184 1.6× 57 0.6× 128 1.5× 51 0.8× 23 277
Ethan Barnett United States 8 291 1.4× 183 1.6× 144 1.6× 185 2.1× 39 0.6× 16 416
Marie‐Therese Haider Germany 11 57 0.3× 232 2.0× 150 1.7× 86 1.0× 43 0.7× 16 332
George Horng United States 9 90 0.4× 139 1.2× 130 1.5× 69 0.8× 92 1.4× 12 344
Aiko Nagayama Japan 9 92 0.4× 274 2.4× 74 0.8× 100 1.1× 97 1.5× 27 394
Yiyi Ji China 7 99 0.5× 85 0.7× 166 1.9× 105 1.2× 27 0.4× 13 309
Ron Korn United States 8 68 0.3× 206 1.8× 104 1.2× 83 1.0× 71 1.1× 26 350
Xianjing Chu China 7 100 0.5× 201 1.7× 127 1.4× 61 0.7× 39 0.6× 12 399
Brad Foulk United States 6 67 0.3× 109 0.9× 94 1.1× 69 0.8× 31 0.5× 12 208

Countries citing papers authored by Taylor Ryan McFarland

Since Specialization
Citations

This map shows the geographic impact of Taylor Ryan McFarland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taylor Ryan McFarland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taylor Ryan McFarland more than expected).

Fields of papers citing papers by Taylor Ryan McFarland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taylor Ryan McFarland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taylor Ryan McFarland. The network helps show where Taylor Ryan McFarland may publish in the future.

Co-authorship network of co-authors of Taylor Ryan McFarland

This figure shows the co-authorship network connecting the top 25 collaborators of Taylor Ryan McFarland. A scholar is included among the top collaborators of Taylor Ryan McFarland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taylor Ryan McFarland. Taylor Ryan McFarland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gebrael, Georges, Nicolas Sayegh, Nishita Tripathi, et al.. (2024). Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting. The Prostate. 84(9). 888–892. 1 indexed citations
2.
3.
4.
McFarland, Taylor Ryan, Vinay Mathew Thomas, Roberto Nussenzveig, et al.. (2022). Detection of BRCA1, and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting. Biomedicines. 10(12). 3170–3170. 2 indexed citations
5.
Swami, Umang, Nicolas Sayegh, Yeonjung Jo, et al.. (2022). External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer. Molecular Cancer Therapeutics. 21(12). 1857–1861. 5 indexed citations
6.
7.
Lin, Edwin, Andrew W. Hahn, Roberto Nussenzveig, et al.. (2021). Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform. The Oncologist. 26(9). 751–760. 11 indexed citations
8.
McFarland, Taylor Ryan, Adam Kessel, Umang Swami, & Neeraj Agarwal. (2021). Development of PARP inhibitor combinations for castration resistant prostate cancer unselected for homologous recombination repair mutations.. PubMed. 13(7). 7427–7439. 3 indexed citations
9.
McFarland, Taylor Ryan, et al.. (2021). Emergence of polyclonal BRCA2 reversions following PARP inhibitor treatment: An illustrative case report. Cancer Treatment and Research Communications. 29. 100480–100480.
10.
McFarland, Taylor Ryan, et al.. (2021). Immune Checkpoint Inhibitors in Prostate Cancer. Cancers. 13(9). 2187–2187. 65 indexed citations
11.
Swami, Umang, Jennifer A. Sinnott, Benjamin Haaland, et al.. (2021). Treatment Pattern and Outcomes with Systemic Therapy in Men with Metastatic Prostate Cancer in the Real-World Patients in the United States. Cancers. 13(19). 4951–4951. 30 indexed citations
12.
Maughan, Benjamin L., Adam Kessel, Taylor Ryan McFarland, et al.. (2021). Radium-223 Plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. The Oncologist. 26(12). 1006–e2129. 20 indexed citations
13.
Kessel, Adam, Taylor Ryan McFarland, Nicolas Sayegh, et al.. (2021). Randomized phase II trial of radium-223 (RA) plus enzalutamide (EZ) versus EZ alone in metastatic castration-refractory prostate cancer (mCRPC): Final efficacy and safety results.. Journal of Clinical Oncology. 39(6_suppl). 135–135. 1 indexed citations
14.
Swami, Umang, Taylor Ryan McFarland, Roberto Nussenzveig, & Neeraj Agarwal. (2020). Advanced Prostate Cancer: Treatment Advances and Future Directions. Trends in cancer. 6(8). 702–715. 148 indexed citations
15.
Rathi, Nityam, Taylor Ryan McFarland, Roberto Nussenzveig, Neeraj Agarwal, & Umang Swami. (2020). Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer. Drugs. 81(2). 191–206. 13 indexed citations
16.
Swami, Umang, Jonathan Chipman, Taylor Ryan McFarland, et al.. (2020). Genomic alterations in visceral versus nonvisceral “metastatic” site tumor tissue in metastatic prostate cancer (mPC).. Journal of Clinical Oncology. 38(6_suppl). 167–167. 1 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mamta Parikh Breakdown of academic impact, for papers by Ning Liao Breakdown of academic impact, for papers by Ethan Barnett Breakdown of academic impact, for papers by Marie‐Therese Haider Breakdown of academic impact, for papers by George Horng Breakdown of academic impact, for papers by Aiko Nagayama Breakdown of academic impact, for papers by Yiyi Ji Breakdown of academic impact, for papers by Ron Korn Breakdown of academic impact, for papers by Xianjing Chu Breakdown of academic impact, for papers by Brad Foulk
Rankless by CCL
2026